Perioperative Lidocaine in Enhanced Recovery After Major Non-Cardiac Surgery
Official title: The Impact of Perioperative Lidocaine Infusions on Enhanced Recovery After Non-Cardiac Surgery (IMPALA ERAS)
Run by Vanderbilt University Medical Center · NCT07224711 · Data updated 2026-11-12
This trial tests whether giving IV lidocaine during major non-cardiac surgery helps recovery and reduces opioid use in adults within an ERAS program.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 2290 (estimated) |
| Sponsor | Vanderbilt University Medical Center Academic / other |
| Locations | 1 site (Nashville, Tennessee) |
| Status | Recruiting |
| Started | October 26, 2026 |
| Main results expected | October 31, 2028 |
| Study ends | October 31, 2028 |
| Registry record updated | November 2, 2026 |
| Trial ID | NCT07224711 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (≥18) undergoing major elective non-cardiac surgery in colorectal, emergency general surgery, urology, ventral hernia, surgical oncology, or spine services, within the Vanderbilt ERAS program.
✕Probably not a fit
Patients who have contraindications to lidocaine, undergo emergent or same-day surgery, or receive a regional or epidural pain regimen may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a single-center, pragmatic, randomized, blinded, placebo-controlled trial assessing the effect of perioperative intravenous lidocaine within an ERAS pathway on outcomes after major non-cardiac surgery. Participants receive lidocaine HCl 0.8% in D5W as part of multimodal pain management. The study compares hospital length of stay adjusted for patient mix, inpatient opioid use, pain levels, return of bowel function, nausea, infections, ICU transfers, and other surgical outcomes, while monitoring for adverse effects. Eligible patients are adults (18+) undergoing major elective non-cardiac surgery in specified specialties, with ASA I–IV; several contraindications apply. The primary sponsor is Vanderbilt University Medical Center.
Why it matters
Potential benefit: If successful, patients may experience shorter hospital stays and lower opioid needs after major non-cardiac surgery.
How similar studies have gone: Previous evidence suggests perioperative lidocaine can reduce pain and opioid use in some surgical populations, but results vary by setting and protocol.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion criteria: * Age greater than or equal to 18 * American Society of Anesthesiologists (ASA) class I-IV * Presenting for major elective, non-cardiac surgery on the colorectal, emergency general surgery, urology, ventral hernia, surgical oncology, or spine services on a weekday * First surgery in the study period (if a patient has multiple surgeries, only the first will be included) Exclusion criteria: * ASA class \>IV * Emergent procedures * Allergy or any contraindication to lidocaine infusion * Patient refusal * Unable to receive or refusal to receive a regional nerve block * Patients who receive an epidural due to standard of care * Direct transfer from operating room to ICU with endotracheal tube in place * Treating team determines patient ineligible prior to study drug administration * Same day surgery * Pregnancy (all female patient of child-bearing age will undergo a pregnancy test the day of surgery)
Where it's running
-
Vanderbilt University Medical Center
Nashville, Tennessee, United States Recruiting
Study contacts
- Principal investigator: Danial Shams, MD — Vanderbilt University Medical Center
- Study coordinator: Danial Shams, MD
- Email: danial.shams@vumc.org
- Phone: 615-936-3198
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Suzetrigine for pain relief after knee replacement
This trial tests whether suzetrigine can reduce opioid use after a total knee replacement compared with placebo.
-
Postoperative tizanidine addition after pelvic reconstructive surgery
This study tests whether adding tizanidine to the usual postoperative pain plan helps adult women recover better after urogynecologic pelvic reconstructive surgery.
-
Combined PECS II and PIP blocks vs TPVB for post-mastectomy pain relief
This trial tests whether a combination of PECS II and superficial PIP blocks can provide better or similar pain relief after mastectomy compared with the standard thoracic paravertebral block.
-
Precision pain management plan using suzetrigine in high-risk surgical patients
In people at high risk for long-term opioid use after surgery, this trial tests whether taking suzetrigine around the time of surgery reduces overall opioid use in the first 14 days postoperatively.
-
SPSIP Block to Help Pain After Breast Reduction Surgery
A randomized trial tests whether adding an ultrasound-guided SPSIP block can lower opioid use in the first 24 hours after bilateral breast reduction surgery.
-
Transauricular Vagus Nerve Stimulation at Different Frequencies for Postoperative Pain
Researchers will test whether different tVNS frequencies can lessen pain and reduce opioid use after abdominal or urologic surgery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.